Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

GORGUN AKPEK

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1124068515
CMS profile
231810
Location
SAN LUIS OBISPO, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$7,960.40

265 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $5,387.98 250
Consulting Fee $1,450.00 3
Long term medical supply or device loan $1,096.70 11
Education $25.72 1

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
AstraZeneca Pharmaceuticals LP $1,683.47 15
Novartis Pharmaceuticals Corporation $1,375.96 27
Janssen Biotech, Inc. $523.71 27
Astellas Pharma US Inc $439.20 11
Merck Sharp & Dohme LLC $368.73 15
GlaxoSmithKline, LLC. $364.34 11
ABBVIE INC. $354.76 15
Daiichi Sankyo Inc. $315.69 20
Exelixis Inc. $245.03 13
Genentech USA, Inc. $243.90 7
PFIZER INC. $231.34 15
Celgene Corporation $193.73 11
Takeda Pharmaceuticals U.S.A., Inc. $175.14 15
Blueprint Medicines Corporation $173.81 4
Lilly USA, LLC $145.40 5
ADC Therapeutics America, Inc. $98.03 4
SOBI, INC $81.97 3
GENZYME CORPORATION $74.61 3
Eisai Inc. $70.41 4
E.R. Squibb & Sons, L.L.C. $66.51 4
Gilead Sciences, Inc. $63.73 3
EMD Serono, Inc. $59.76 3
BeiGene USA, Inc. $51.55 3
Apellis Pharmaceuticals, Inc. $50.10 2
Incyte Corporation $46.40 3
Alexion Pharmaceuticals, Inc. $45.84 2
Alnylam Pharmaceuticals Inc. $39.94 2
Blue Earth Diagnostics Limited $33.16 1
Karyopharm Therapeutics Inc. $32.24 1
Mirati Therapeutics, Inc. $31.03 2
Janssen Pharmaceuticals, Inc $25.72 1
ARRAY BIOPHARMA INC $24.39 1
Deciphera Pharmaceuticals Inc. $23.03 1
TAIHO ONCOLOGY, INC. $22.99 1
Coherus Biosciences Inc. $22.93 1
SERVIER PHARMACEUTICALS LLC $22.47 1
SpringWorks Therapeutics, Inc. $21.69 1
Boehringer Ingelheim Pharmaceuticals, Inc. $21.42 1
Fresenius Kabi USA, LLC $20.71 1
Aveo Pharmaceuticals, Inc. $18.81 1
SUN PHARMACEUTICAL INDUSTRIES INC. $17.29 1
MorphoSys, US Inc. $15.58 1
Agios Pharmaceuticals, Inc. $14.76 1
Janssen Scientific Affairs, LLC $9.12 1

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

265 matching records · $7,960.40 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 265 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 265.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Eisai Inc. $13.9012/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110747250 CMS
Exelixis Inc. $16.9812/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261138558202 CMS
Celgene Corporation $1.0912/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101100190 CMS
Celgene Corporation $13.4512/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101100192 CMS
Takeda Pharmaceuticals U.S.A., Inc. $25.3712/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261144952297 CMS
Novartis Pharmaceuticals Corporation $99.7012/10/2024 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/20261086692301 CMS
Alexion Pharmaceuticals, Inc. $21.6812/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261093974384 CMS
Janssen Biotech, Inc. $15.8912/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261078335583 CMS
ABBVIE INC. $27.9712/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261103191930 CMS
Exelixis Inc. $21.4311/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261138558200 CMS
PFIZER INC. $17.9411/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261131384838 CMS
Daiichi Sankyo Inc. $26.7911/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089391826 CMS
PFIZER INC. $20.2411/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261131387064 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.4211/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261117880952 CMS
Novartis Pharmaceuticals Corporation $31.9611/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261086692299 CMS
EMD Serono, Inc. $21.8411/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120273546 CMS
PFIZER INC. $5.7311/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261131265751 CMS
Blueprint Medicines Corporation $30.9411/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261147441642 CMS
GlaxoSmithKline, LLC. $29.9811/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261116617474 CMS
Daiichi Sankyo Inc. $26.1911/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089391824 CMS
Janssen Biotech, Inc. $3.2511/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261078335242 CMS
Janssen Biotech, Inc. $18.3111/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261078335458 CMS
Novartis Pharmaceuticals Corporation $99.7011/14/2024 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/20261086692291 CMS
Novartis Pharmaceuticals Corporation $22.3011/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261086692295 CMS
Astellas Pharma US Inc $110.3111/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139452396 CMS
GENZYME CORPORATION $13.7011/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139713158 CMS
Janssen Biotech, Inc. $51.3011/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261078334627 CMS
Exelixis Inc. $24.6311/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261138558198 CMS
AstraZeneca Pharmaceuticals LP $24.2611/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104676317 CMS
BeiGene USA, Inc. $20.6811/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120860851 CMS
Janssen Biotech, Inc. $20.7411/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261078335622 CMS
Gilead Sciences, Inc. $30.4110/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133806377 CMS
Daiichi Sankyo Inc. $0.7710/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089391820 CMS
GlaxoSmithKline, LLC. $99.1610/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261116728734 CMS
Daiichi Sankyo Inc. $26.8510/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089391822 CMS
Celgene Corporation $11.4710/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101100186 CMS
E.R. Squibb & Sons, L.L.C. $16.5510/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101289120 CMS
Genentech USA, Inc. $14.1310/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133015783 CMS
AstraZeneca Pharmaceuticals LP $525.0010/24/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104757510 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.7210/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261144952293 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2.0110/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261144952295 CMS
Incyte Corporation $15.8110/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141276806 CMS
Agios Pharmaceuticals, Inc. $14.7610/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261149645522 CMS
BeiGene USA, Inc. $15.1410/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120860853 CMS
Alnylam Pharmaceuticals Inc. $24.0310/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261125858671 CMS
Novartis Pharmaceuticals Corporation $99.7010/17/2024 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/20261086692293 CMS
Takeda Pharmaceuticals U.S.A., Inc. $9.4410/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261144952291 CMS
Genentech USA, Inc. $15.1210/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133015767 CMS
Janssen Biotech, Inc. $12.4310/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261078334874 CMS
Janssen Pharmaceuticals, Inc $25.7210/15/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/20261077940500 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,505.07 68
PY2020 $2,785.32 158
PY2021 $5,260.49 210
PY2022 $4,006.68 207
PY2023 $3,878.19 204
PY2024 $7,960.40 265
PY2025 $7,201.96 240

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
GORGUN AKPEK, NPI 1124068515. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1124068515.
APA 7
IndustryPayments. (2026). GORGUN AKPEK, NPI 1124068515 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1124068515
Bluebook
GORGUN AKPEK, NPI 1124068515, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1124068515.

Source: Centers for Medicare & Medicaid Services, Open Payments.